Mice were immunized with eight different serotypes of avian paramyxovirus (PMV). The number of splenocytes that formed antibody to PMV-infected Madin-Darby bovine kidney cells was determined by immunoperoxidase staining. Microscopic examination revealed brown plaques of cell surface or inclusion body-like antigen comprising the glycoprotein or nucleoprotein-polymerase complex, respectively. The IgG response to virus glycoprotein was priming-dependent and 99~ serotype-specific, a value which exceeds that of PMV typing using avian serology. The response to inclusion body-like antigens was more variable and less priming-dependent and suggested cross-reactivities between PMV-1 and PMV-3 or -9. The primary IgM response also included a 1 to 10~o non-specific antibody response to host antigens revealed by neuraminidase treatment.
INTRODUCTION
Avian paramyxovirus (PMV) serotypes 1 to 9 are defined by haemagglutination inhibition (HI) tests in chickens although low cross-reactive titres occur between serotypes (Alexander, 1980 (Alexander, , 1986 Alexander et al., 1983a) . The most obvious cross-reactivity is between Newcastle disease virus (NDV) (PMV-I) and PMV-3. This cross-reactivity is accompanied by crossprotection (Alexander et al., 1979) , cross-lymphocyte stimulation (Cannon & Russell, 1988) and recall of HI antibody to one serotype as a result of subsequent infection with the other (Alexander et al., 1979 (Alexander et al., , 1983 . The most recently described serotype, PMV-9, also cross-reacts with PMV-1 and -3 in HI tests (Alexander et al., 1983a) and with PMV-1 by neuraminidase inhibition (Lipkind & Shihmanter, 1986) . Mouse monoclonal antibodies (MAbs) to PMV-1, -2 or -3 define conserved and variable epitopes within each serotype whereas chicken antisera do not. MAbs for shared epitopes are rare (Abenes et al., 1986a) and are outnumbered by nonspecific anti-carbohydrate MAbs which can bind to influenza virus-infected cells (Abenes et al., 1986b) or cells treated with bacterial neuraminidase (Anderson & Russell, 1988) . The present work uses mice and a new antibody-forming cell (AFC) assay to examine PMV typing.
The conventional AFC assay did not differentiate between immunoglobulin classes and was improved to enumerate IgM-and IgG-secreting AFCs. These three assays were compared in an experiment on the kinetics of primary and secondary immune responses to intravenous injections of PMV-3. AFC antibody plaque size was also measured because this relates to antibody affinity (Holt et al., 1984) . This established that the IgM response was maximal 4 days after the primary inoculation and the IgG response was maximal 4 days after the second inoculation. Mice were therefore killed at these times in the specificity experiments.
Mice were first immunized in a fully orthogonal specificity study using all eight available PMV serotypes. One or two additional isolates of PMV-1, -2 and -3 that were shown by MAbs to differ in the variable epitopes (Meulemans et al., 1987; P. H. Russell, I. Ozdemir & D. J. Alexander, unpublished data; Anderson et al., 1987) were also used.
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In three of five earlier experiments using the conventional AFC assay, a cross-reactivity between the internal virion proteins of PMV-1 and PMV-9 was observed (P. H. Russell & I. Ozdemir, unpublished results) . Internal virion proteins provide T cell help for the 4 day murine HI response to influenza virus (Russell & Liew, 1979) ; therefore, the ability of PMV-1, -3 and -9 to augment the 4 day IgG AFC response to each other was examined. PMV-1 and PMV-3 stimulate recall of avian HI antibodies to each other in a manner reminiscent of original antigenic sin (Alexander et al., 1983b) and so the effect of a second serotype given on day 24, 4 days before AFC assay of the IgG response to the first serotype, was recorded in this crosspriming experiment. Such recall could be taken as evidence for cross-reactivity at the B cell level. (Russell et al., 1983) . Serotype PMV-5/budgerigar/Japan/Kunitachi/74 was not available because of its poor growth in eggs (D. J. Alexander, personal communication). The viruses were passaged once or twice in the allantoic cavity of eggs to a titre of 106.6 to 108 infectious units in 0.1 ml by indirect immunoperoxidase (IIP) staining (Russell et al., 1983) and used as allantoic fluid throughout this work.
METHODS

Viruses
In the kinetics and cross-priming experiments inoculated viruses were buffered with 0.05 M-Tris-HC1 pH 7.5 and inactivated with fl-propiolactone (flPL) donated by Dr I. Furminger (Glaxo) before inoculation into mice.
flPL was used at 0.5 ~ for 1 h at 37 °C when the process was repeated and then continued overnight at 4 °C. The virus was non-infectious as assessed by the failure of allantoic fluid to haemagglutinate after 0.2 ml was passaged three times through eggs from antibody-negative flocks.
AFC assay. The technique used was described by Russell et al. (1987) . Splenocytes (105, 106 or 107) were centrifuged into semi-microwells containing Madin-Darby bovine kidney cells which had been infected with virus overnight and fixed with formaldehyde. Plaques of secreted antibody were detected after 3 h at 37 °C by IIP staining of mouse immunoglobulins. Cells forming antibody that bound the nucleoprotein-polymerase complex stained intracytoplasmic inclusion body-like material. Antibody that bound glycoprotein antigens stained the plasma membranes with some paler diffuse staining of the cytoplasm.
The assay was modified so that IgG and IgM AFCs were separately counted by using 10 -3 affinity-purified goat anti-~ or anti-# chain (Sera-lab) followed by 10 -2.8 anti-goat Ig conjugate (Dako). Bovine serum albumin (2~) used to block the reaction and during incubations (0.5%) instead of newborn calf serum gave improved plaque definition. Results were expressed as AFC/107 splenocytes.
Kinetics of the AFC response to PMV-3. Age-matched adult BALB/c mice received 0-1 ml of flPL-treated PMV-3 (MPH) by the intravenous route. Three mice were separately assayed at intervals of 1, 2, 3, 4, 7, 10, 14 and 20 days for splenic AFCs secreting Ig, IgG or IgM. The remaining mice were then re-immunized and assayed at the same intervals.
Serotype specificity of the AFC response. Spleens were pooled from age-matched groups of three BALB/c mice that had received 0.1 ml of infectious PMV of each serotype intravenously. IgM AFCs were assayed 4 days after priming. IgG AFCs were assayed 4 days after secondary inoculation of mice which had been primed 1 month earlier. AFC counts were determined using cells infected with each PMV serotype and Sendai virus and on cells treated with bacterial neuraminidase (Russell, 1981) as well as uninfected cells.
Cross-priming between PMV-1, -3 and -9. Groups of three mice were primed intravenously and then boosted 28 days later with all combinations of flPL-inactivated PMV-1 (Ulster), PMV-3 (MPH), PMV-9 and no virus. After 4 days IgG and IgM AFCs from individual mice were assayed for staining of the surface of cells infected with PMV-1, 3 or 9 and of uninfected cells.
RESULTS
Kinetics of the AFC responses to PMV-3 (MPH)
Using anti-y and anti-# chain facilitating antibodies AFC responses were detected 1 day after inoculation and reached values of about 10 z IgG AFCs and 104 IgM AFCs by 4 days (Fig. 1) . IgG AFCs continued at 102 from 4 days post-inoculation (p.i.) onwards. IgM AFCs peaked at 104 at 4 days p.i. and then dropped to the IgG level of 10 z from 7 to 20 days p.i. (Fig. 1) . 
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Secondary peaks occurred 4 days after reinoculation when IgG AFCs increased 30-fold to 103"5, therefore exceeding secondary IgM AFC levels of 103. Class switching for IgM and IgG had therefore occurred. Ten-to 100-fold more antibody bound to the cell surface antigens as compared to the inclusion body-like antigens. The mean diameter of the IgM plaques remained constant at about 60 Ixm whereas IgG plaques increased up to 88 Ilm in the primary response and up to 100 txm in the secondary response (Fig. 2) . IgG plaques were larger than IgM plaques with the exception of a less than significant result on day 20 (Fig. 2) .
The former assay (with the direct conjugate) failed to detect any AFCs at 1 day ( Fig. 3 ) and recorded a peak primary response which was 10-fold less than the IgM response. The plaques of antibody were pale and less than 55 Ixm until 7 days p.i. when they enlarged steadily to the same peak size (100 ~tm at 21 days p.i.) as the IgG plaques (Fig. 4) .
Serotype specificity of the secondary IgG AFC response
Mice produced 103 to 104 IgG AFCs/107 splenocytes for each serotype of PMV. The majority of the secreted antibody stained the surface of cells infected with the inoculated virus. No crossreactivity was detected between PMV serotypes (Table 1) .
Mice did not distinguish between vaccinal PMV-1 isolates from chickens. They did distinguish between PMV-2 or PMV-3 isolates from separate species by a five-to 60-fold difference in AFC response and the antibody formed smaller plaques on cells infected with the heterologous isolate (Table 1 ). This intraserotypic response to different PMV-2 or -3 isolates exceeded the interserotypic response to different serotypes by at least 100-fold.
Accompanying responses to inclusion body-like antigens were detected on PMV-1, -3 and -6-infected cells. They were 10-fold lower than those to cell surface antigens and were virus serotype-specific. 
Serotype specificity of the primary IgM AFC response
Mice produced 102 to 103.4 IgM AFCs secreting antibody that bound to the surface proteins of cells infected with the immunizing serotype ( Table 2) . Any response that exceeded 103 AFC was more than 30-fold serotype-specific.
Cross-reactive antiviral AFC responses to heterologous serotypes were widespread and low at < 102"1 and were accompanied by AFC responses to cells treated with bacterial neuraminidase ( Table 2 ). The mean response of all the virus-immune mice to cells infected with heterologous PMV serotypes or treated with bacterial neuraminidase were not greatly different at 1011 ~ -+ 0.03 and 10 TM _+0-05 respectively where 0-05 < P< 0.1. The mean response of the same mice to untreated ceils was smaller at 10 °6_+°°9, p < 0.01. Non-specific AFC antibody responses to neuraminidase-revealed host cell antigens which have been described earlier (Russell, 1981) therefore obscured the detection of cross-reactive IgM AFCs. There was an occasional response to a second serotype which exceeded that on neuraminidase-treated cells by threefold, e.g. PMV-1-immune mice on PMV-9 cells, PMV-7-immune mice on PMV-1 cells (LaSota) and PMV-8-immune mice on PMV-2 cells (Ploc-9) ( Table 2 ) but all these cross-reactions were one-way and considered to be doubtful. Less than 101"3 cells forming IgM to inclusion-body-like antigens were detected, except in the case of mice immunized with all PMV-1 and PMV-3 isolates; when assayed on PMV-1 (Ulster)-infected cells there were 102'5 to 103 AFCs (results not shown). This supported the known crossreactivity between these serotypes but the experiment was limited by the very low values obtained using cells infected with other viruses.
Cross-priming and recall of IgG responses to the cell surface antigens of PMV-1, -3 and -9
When AFC IgG responses to cell surface antigens were assayed 4 days p.i. the AFCs numbered less than 30. When mice had been inoculated 1 month earlier (primed) with the same virus, the number of IgG AFCs increased by 40-to 100-fold (Table 3 ) whereas the number of IgM AFCs decreased by eight-to 60-fold (Table 3 ). In mice that had been inoculated 1 month earlier with a different serotype (cross-primed) IgG AFCs increased threefold with an accompanying decrease in IgM AFCs with respect to combinations of PMV-1 and PMV-3 or PMV-1 and PMV-9. PMV-3 and PMV-9 did not give this cross-priming effect. As only three mice were tested in any group the increase in IgG AFCs due to cross-priming was not statistically significant except for PMV-3 cross-priming an anti-PMV-1 response (Table 3) .
After the initial inoculation the number of cells forming anti-PMV-3 IgG was higher at 4 days p.i. than at 28 days p.i. as expected from the kinetics experiment (Fig. 1) whereas the number of cells forming antibodies to PMV-1 and PMV-9 had increased 10-and fourfold over this period (Table 3) . If PMV-I-and PMV-9-immune mice were boosted with PMV-9 and PMV-1, respectively, 24 days p.i. and assayed at 28 days p.i., the AFC responses to the first (priming) virus were further increased by six-and 10-fold. This is termed recall. 
Specificity of primary lgM AFCs to cell surface antigens using facilitating antibody
Immunizing serotype Vibrio cholerae neuraminidase (Russell, 1981 
DISCUSSION
The IgG and IgM AFC responses were always predominantly directed towards the virus envelope proteins on the cell surface. The IgG responses were augmented by priming. Responses to inclusion body-like antigens were only regularly obtained using NDV (Ulster)-infected cells in the assay.
The primary and secondary responses to the glycoprotein antigens of PMV-3 and other PMV serotypes involved a switch from small IgM plaques to large IgG plaques. The primary IgM AFCs contained a subpopulation of non-specific AFCs secreting antibody that bound to the surface of cells infected with avian or mammalian paramyxoviruses via neuraminidase-revealed antigens.
Avian PMV-3 elicited a rapid AFC response in mice. IgG and IgM AFCs were first detected 1 day after immunization and the responses peaked between 4 and 7 days p.i. (Fig. 1) . This day 1 response is not without precedent; murine AFCs secreting IgG and IgM to sheep red blood cells given by the less direct intraperitoneal route were detected at the first sampling time of 2 days p.i. (Wortis et al., 1969) . The rapid induction of primary IgG AFCs to PMV-3 may not be typical of all PMV serotypes because the IgG response to PMV-1 or PMV-9 increased between 4 to 28 days p.i. (Table 3) .
Primary IgM AFCs and secondary IgG AFCs to the cell surface antigens failed to distinguish between three vaccinal isolates from chickens but were able to separate PMV-2 and PMV-3 isolates from different species. This relates to the vaccinal PMV-1 isolates having more shared epitopes detectable by analysis using MAbs (D. J. Alexander, C. L. Anderson, I. Ozdemir & P. H. Russell, unpublished results) . The smaller size of the heterologous PMV-2-and PMV-3-infected cell plaques implied antibody to the shared antigens of these viruses was of lower affinity than that to their unique antigens. The intraserotypic IgG AFC responses were 100-fold greater than those to different PMV serotypes. This 100-fold margin for distinguishing serotypes is wider than that using avian antisera in HI tests when a low intraserotypic titre of 40 can equal a high interserotypic titre (Alexander, 1980; Alexander et al., 1983a) .
Evidence for cross-reactivity between serotypes came from cross-priming for IgG AFCs between PMV-1 and PMV-3/PMV-9. Cross-priming did not result from a mouse response to allantoic fluid because PMV-3 and PMV-9 did not cross-prime. The PMV-1 and PMV-9 crossreactivity was supported by the ability of these viruses to recall each other (Table 3) and by the preliminary specificity experiments which showed inclusion body-like antigens shared by PMV-1 and PMV-9. These were not repeated here because the responses to inclusion body-like antigens were poor. The PMV-1 and -3 cross-reactivity was supported by the ability of PMV-3 to elicit an IgM primary response to inclusion body-like antigens on NDV (Ulster)-infected cells. Although the cross-reactivity between PMV-1 and -3 is already well established, the present work re-emphasizes the cross-reactivity between PMV-1 and -9 and suggests that not only the envelope glycoprotein but also the nucleoprotein-polymerase complex can carry antigens that are shared between certain PMV serotypes. This work was supported by grant AG48/60 awarded by the Agriculture and Food Research Council to P. H. Russell.
